Endogenous stem cell therapy enhances fat graft survival

Area of Science:

• Regenerative Medicine
• Adipose Tissue Engineering
• Stem Cell Biology

Background:

• Lipoaspirate centrifugation yields adipose tissue of varying densities.
• High-density fat exhibits superior graft survival due to higher levels of vasculogenic cytokines and progenitor cells.
• Low-density fat has lower graft survival rates compared to high-density fat.

Purpose of the Study:

• To investigate whether enhancing the bone marrow-derived progenitor cell response in low-density fat grafts can improve their survival.
• To determine if mobilizing endogenous progenitor cells can augment the regenerative potential of low-density fat grafts.

Main Methods:

• Human lipoaspirate was centrifuged to obtain high-density and low-density fat.
• FVB mice were grafted with either high-density or low-density fat.
• A subset of mice receiving low-density fat was treated with a stem cell mobilizer (AMD3100) for 14 days.
• Graft survival and cellular/molecular markers were analyzed at 2 and 10 weeks.

Main Results:

• Low-density fat grafts treated with AMD3100 showed significantly improved survival (61.2%) compared to untreated low-density fat (26%) at 2 weeks (p<0.01).
• AMD3100 treatment increased circulating vasculogenic progenitor cells and enhanced neovascularization within the grafts (p<0.01).
• Both AMD3100-treated low-density fat and high-density fat grafts exhibited increased expression of stromal-derived factor-1α and vascular endothelial growth factor.

Conclusions:

• Mobilization of endogenous progenitor cells effectively enhances neovascularization and vasculogenic cytokine expression in low-density fat grafts.
• This approach significantly improves low-density fat graft survival, achieving outcomes comparable to high-density fat grafts.
• Stem cell mobilization represents a promising strategy to improve the clinical efficacy of low-density fat grafting.